Home›Companies›Biotech & Pharma›32 Biosciences

32 Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing May 31, 2024·Suggest an edit

About 32 Biosciences

32 Biosciences is a private company based in Illinois, Illinois, incorporated in 2023 in Illinois. It has reported $160,000 raised in one offering on Form D since May 2024. Its chief executive is Peter Farmakis.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 21, 2024May 31, 2024$160,000of $6.0M target3$53,333Equity, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on 32 Biosciences's Form D filed May 31, 2024.

JP
BY
Brian Yoor
Director
EC
Eugene Chang
Director
JC
JA
John Alverdy
Director
PF
Peter Farmakis
Chief Executive Officer and director

Sources

  1. SEC32 Biosciences, Inc. filing history